CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Board of Directors

The 13-member CADTH Board of Directors is composed of an independent chair; a regional distribution of jurisdictional federal, provincial, and territorial representatives; and a number of non-jurisdictional representatives from health systems, academia, and the general public. Directors are elected by the Members of the Corporation, who are the Deputy Ministers of Health for participating federal, provincial, and territorial governments.

The Board has overall responsibility for administering the affairs of the Corporation and providing the strategic direction to guide CADTH's success as the Canadian "go-to" provider of evidence and advice on the use of drugs and other health technologies.

Chair of the Board

David AgnewDavid Agnew



Marcel SaulnierMarcel Saulnier
Associate ADM, Strategic Policy Branch

Western Provinces

Mitch MoneoMitch Moneo
Assistant Deputy Minister, Pharmaceutical Services Division, Ministry of Health, British Columbia

Mark WyattMark Wyatt
Assistant Deputy Minister, Saskatchewan Ministry of Health


Stephen SamisStephen Samis
Deputy Minister, Health and Social Services, Government of Yukon


Patrick DicerniMr. Patrick Dicerni
Assistant Deputy Minister, Drugs and Devices Division and Executive Officer, Ontario Public Drug Programs 

Atlantic Provinces

Jeannine LagasséJeannine Lagassé
Associate Deputy Minister of Health and Wellness, Province of Nova Scotia.

Karen Stone
Deputy Minister of Health and Community Services (NL)

Health Systems

Dr. Brendan CarrDr. Brendan Carr
President and CEO of the Nova Scotia Health Authority

Dr. Charmaine RoyeDr. Charmaine Roye
Physician, Ottawa


Cathy McIntyreCathy McIntyre
Principal of Strategic Initiatives

Ellen PekilisEllen Pekilis
Legal, Risk and Governance Advisor


Dr. Stuart PeacockDr. Stuart Peacock
Leslie Diamond Chair in Cancer Survivorship and Professor, Faculty of Health Sciences, Simon Fraser University; Co-Director, the Canadian Centre for Applied Research in Cancer Control (ARCC); and Distinguished Scientist in Cancer Control Research, British Columbia Cancer Agency

Observer (Quebec)

Dr. Luc BoileauDr. Luc Boileau
President and CEO, Institut national d’excellence en santé et en services sociaux (INESSS)